Abstract
The p53 tumor suppressor gene is the most commonly mutated gene in cancer (1,2) and is mutated in 50% non-small cell lung cancer (NSCLC) and 70% of small cell lung cancer (SCLC) (3). Mutations in p53 commonly reflect exposures to environmental carcinogens, e.g., cigarette smoke and lung cancer or aflatoxin and liver cancer. In support for tobacco smoking as a major risk factor for lung cancer, as the content of tar and nicotine per cigarette has dropped by more than two-thirds, there has been a concomitant change in the histologic type of lung cancer (4). While SCLC has persisted at about 20%, adenocarcinoma has increased to 45% with declines in squamous cell and large cell carcinoma. Thun and colleagues (5) have suggested that these changes are due to the design of the cigarette; e.g., filter-tip cigarettes are inhaled more deeply than earlier, unfiltered cigarettes (more toxic), and deeper inhalation transports tobacco-specific carcinogens more distally toward the bronchoalveolar junction where adenocarcinomas often arise. In human lung cancer, both the frequency and type of mutations in the p53 gene can act as fingerprints providing information about external etiological agents, carcinogen exposure, and host factors affecting the carcinogenesis process (6).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Levine, A. J., Momand, J., and Finlay, C. A. (1991) The p53 tumour suppressor gene. Nature 351, 453ā456.
Vogelstein, B., Lane, D., and Levine, A. J. (2000) Surfing the p53 network. Nature 408, 307ā310.
Greenblatt, M. S., Bennett, W. P., Hollstein, M., and Harris, C. C. (1994) Muta-tions in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. 54, 4855ā4878.
Fielding J. E. (1985) Smoking: health effects and control. N. Engl. J. Med. 313, 491ā498, 555ā562.
Thun, M. J., Lally, C. A., Flannery J. T., Calle, E. E., Flanders, W. D., and Heath, C. W. (1997) Cigarette smoking and changes in the histopathology of lung cancer. J. Natl. Cancer Inst. 89, 1580ā1586.
Bartsch, H. and Hietanen, E. (1996) The role of individual susceptibility in cancer burden related to environmental exposure. Environ. Health Perspect. 104S3, 569ā577.
Hernandez-Boussard, T. M. and Hainaut, P. (1998) A specific spectrum of p53 mutations in lung cancer from smokers: review of mutations compiled in the IARC p53 database. Environ. Health Perspect. 106, 385ā391.
Harris, C. C. (1996) Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies. J. Natl. Cancer Inst. 88, 1442ā1455.
Denissenko, M. F., Pao, A., Tang, M. S., and Pfeifer, G. P. (1996) Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in p53. Science 274, 430ā432.
Malkin, D., Li, F. P., Strong, L. C., Fraumeni, J. F., Jr., et al. (1990) Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250, 1233ā1238.
Malkinson, A. M. (1998) Molecular comparison of human and mouse pulmonary adenocarcinomas. Exp. Lung Res. 24, 541ā555.
Herzog, C. R., Lubet, R. A., and You, M. (1997) Genetic alterations in mouse lung tumors: implications for cancer chemoprevention. J. Cell Biochem. Suppl. 28-29, 49ā63.
Serrano, M. (2000) The INK4Ī±/ARF locus in murine tumorigenesis. Carcinogen-esis 21, 865ā869.
You, M., Candrian, U., Maronpot, R. R., Stoner, G. D., and Anderson, M. W. (1989) Activation of the Ki-ras protooncogene in spontaneously occurring and chemically induced lung tumors of the strain A mouse. Proc. Natl. Acad. Sci. USA 86, 3070ā3074.
Mass, M. J., Jeffers, A. J., Ross, J. A., Nelson, G., Galati, A. J., Stoner, G. D., and Nesnow, S. (1993) Ki-ras oncogene mutations in tumors and DNA adducts formed by benz[j]aceanthrylene and benzo[a]pyrene in the lungs of strain A/J mice. Mol. Carcinogenesis 8, 186ā192.
Shafarenko, M., Mahler, J., Cochran C., Kisielewski, A., Golding, E., Wiseman, R., and Goodrow, T. (1997) Similar incidence of K-ras mutations in lung carcinomas of FVB/N mice and FVB/N mice carrying a mutant p53 transgene. Carcinogenesis 18, 1423ā1426.
Lubet, R. A., Zhang, Z., Wiseman, R. W., and You, M. (2000) Use of p53 transgenic mice in the development of cancer models for multiple purposes. Exp. Lung Res. 26, 581ā593.
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Jr., Butel, J. S., and Bradley, A. (1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356, 215ā221.
Harvey, M., McArthur, M. J., Montgomery, C. A., Butel, J. S., Bradley, A., and Donehower, L. A. (1993) Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice. Nature Genet. 5, 225ā229.
Purdie, C. A., Harrison, D. J., Peter, A., Dobbie, L., White, S., Howie, S. E. M., et al. (1994) Tumour incidence, spectrum and ploidy in mice with a large deletion in the p53 gene. Oncogene 9, 603ā609.
Lavigueur, A., Maltby, V., Mock, D., Rossant, J., Pawson, T., and Bernstein, A. (1989) High incidence of lung, bone, and lymphoid tumors in transgenic mice overexpressing mutant alleles of the p53 oncogene. Mol. Cell. Biol. 9, 3982ā3991.
Harvey, M., Vogel, H., Morris, D., Bradley, A., Bernstein, A., and Donehower, L. A. (1995) A mutant p53 transgene accelerates tumor development in heterozygous but not nullizygous p53-deficient mice. Nature Genet. 9, 305ā311.
Zhang, Z., Liu, Q., Lantry, L. E., Wang, Y., Kelloff, G. J., Anderson, M. W., et al. (2000) A germ-line p53 mutation accelerates pulmonary tumorigenesis: p53-independent efficacy of chemopreventive agents green tea or dexamethasone/ myo-inositol and chemotherapeutic agents taxol or adramycin. Cancer Res. 60, 901ā907.
Yoshimoto, T., Inoue, T., Iizuka, H., Nishikawa, H., Sakatani, M., Ogura, T., et al. (1980) Differential induction of squamous cell carcinomas and adenocarcinomas in mouse lung by intratracheal instillation of benzo(a)pyrene and charcoal powder. Cancer Res. 40, 4301ā4307.
Morris G.F., Hoyle G. W., Athas G.B., Lei W. H., Xu, J., Morris C. B.,and Fried-man, M. (1998) Lung-specific expression in mice of a dominant negative mutant form of the p53 tumor suppressor protein. J. LA. State Med. Soc. 150, 179ā185.
Hosokawa, A. (1999) Generation and analyses of transgenic mice containing mutant p53 transgene. Jukuoka Igaku Zasshi 90, 80ā87.
Magdaleno, S. M., Wang, G., Mireles, V. L., Ray, M. K., Finegold, M. J., and DeMayo, F. J. (1997) Cyclin-dependent kinase inhibitor expression in pulmonary Clara cells transformed with SV40 Large T Antigen in transgenic mice. Cell Growth Differ. 8, 145ā155.
Wikenheiser, K. A., Clark, J. C., Linnoila, R. I., Stahlman, M. T., and Whitsett, J. A. (1992) Simian Virus 40 Large T Antigen directed by transcriptional elements of the human surfactant protein C gene produces pulmonary adenocarcinomas in transgenic mice. Cancer Res. 52, 5342ā5352.
Wikenheiser, K. A. and Whitsett, J. A. (1997) Tumor progression and cellular differentiation of pulmonary adenocarcinomas in SV40 Large T Antigen transgenic mice. Am. J. Respir. Cell Mol. Biol. 16, 713ā723.
Pack, R. J., Al-Ugaily, L. H., and Morris, G. (1981) The cells of the tracheobron-chial epithelium of the mouse: a quantitative light and electron microscope study. J.Anat. 132 (Pt 1), 71ā84.
Shaulian, E., Zauberman, A., Ginsberg, D., and Oren, M. (1992) Identification of a minimal transformation domain of p53: negative dominance through abrogation of sequence-specific DNA binding. Mol. Cell. Biol. 12, 5581ā5592.
Sawaya, P. L., Stripp, B. R., Whitsett, J. A., and Luse, D. S. (1993) The lung-specific CC10 gene is regulated by transcription factors from the AP-1, octamer, and hepatocyte nuclear factor 3 families. Mol. Cell. Biol. 13, 3860ā3871.
Bowman, T., Symonds, H., Gu, L., Yin, C., Oren, M., and Van Dyke, T. (1996) Tissue-specific inactivation of p53 tumor suppression in the mouse. Genes Dev. 10, 826ā835.
Nomori, H., Morinaga, S., Kobayashi, R., and Torikata, C. (1994) Protein 1 and Clara cell 10-kDa protein distribution in normal and neoplastic tissues with emphasis on the respiratory system. Virchows Arch. 424, 517ā523.
Szabo, E., Goheer, A., Witschi, H., and Linnoila, R. I. (1998) Overexpression of CC10 modifies neoplastic potential in lung cancer cells. Cell Growth Differ. 9, 475ā485.
Linnoila, R. I., Szabo, E., DeMayo, F., Witschi, H., Sabourin, C., and Malkinson, A. (2000) the role of CC10 in pulmonary carcinogenesis: from a marker to tumor suppression. Ann. NY Ac ad. Sci. 923, 249ā267.
Margraf, L. R., Finegold, M. J., Stanley, L. A., Major, A., Hawkins, H. K., and DeMayo, E J. (1993) Cloning and tissue-specific expression of the cDNA for 480 the mouse Clara cell 10 kD protein: comparison of endogenous expression to rabbit uteroglobin promoter-driven transgene expression. Am. J. Respir. Cell Mol. Biol. 9, 231ā238.
Ray, M. K., Magdaleno, S. W., Finegold, M. J., and DeMayo, F. J. (1995) cis-acting elements involved in the regulation of mouse Clara cell-specific 10-kDa protein gene. In vitro and in vivo analysis. J. Biol. Chem. 270, 2689ā2694.
Ray, M. K., Chen, C. Y., Schwartz, R. J., and DeMayo, F. J. (1996) Transcriptional regulation of a mouse Clara cell-specific protein (mCC10) gene by the NKx transcription factor family members thyroid transciption factor 1 and cardiac muscle-specific homeobox protein (CSX). Mol. Cell. Biol. 16, 2056ā2064.
Mahler, J. F., Stokes, W., Mann, P. C., Takaoka, M., and Maronpot, R. R. (1996) Spontaneous lesions in aging FVB/N mice. Toxicol. Pathol. 24, 710ā716.
Zhan, B., Magdaleno, S., Chua, S., Wang, Y. L., Burcin, M., Elberg, D., et al. (2000) Transgenic mouse models for lung cancer. Exp. Lung Res. 26, 567ā579.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
Ā© 2003 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Tchou-Wong, KM., Rom, W.N. (2003). Lung-Specific Expression of Mutant p53 as Mouse Model for Lung Cancer. In: Driscoll, B. (eds) Lung Cancer. Methods in Molecular Medicineā¢, vol 74. Humana Press, Totowa, NJ. https://doi.org/10.1385/1-59259-323-2:465
Download citation
DOI: https://doi.org/10.1385/1-59259-323-2:465
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-0-89603-985-8
Online ISBN: 978-1-59259-323-1
eBook Packages: Springer Protocols